Western blotting was used to detect the levels of myocardial hypertrophy markers ANP, BNP and β‐MHC, and the results showed that the expression levels of myocardial hypertrophy markers were significantly increased in the SHR model (Figure 3B–D). The gene discussed is NPPA; the disease is cardiac hypertrophy.